These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 15380535
21. Analysis of innate immune responses in a model of IgA nephropathy induced by Sendai virus. Yamashita M, Chintalacharuvu SR, Kobayashi N, Nedrud JG, Lamm ME, Tomino Y, Emancipator SN. Contrib Nephrol; 2007; 157():159-63. PubMed ID: 17495456 [Abstract] [Full Text] [Related]
22. Complement system in IgA nephropathy. Tomino Y. Tokai J Exp Clin Med; 1980 Jan; 5(1):15-22. PubMed ID: 6992349 [Abstract] [Full Text] [Related]
23. The syndrome of IgA nephropathy. Clarkson AR, Woodroffe AJ, Bannister KM, Lomax-Smith JD, Aarons I. Clin Nephrol; 1984 Jan; 21(1):7-14. PubMed ID: 6231147 [Abstract] [Full Text] [Related]
24. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A. J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532 [Abstract] [Full Text] [Related]
25. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Makker SP, Tramontano A. J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232 [Abstract] [Full Text] [Related]
26. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T. Virology; 2007 Mar 01; 359(1):82-91. PubMed ID: 17027894 [Abstract] [Full Text] [Related]
27. [Sendai viral infection and host innate immunity]. Kato A, Kiyotani K. Tanpakushitsu Kakusan Koso; 2007 Aug 01; 52(10 Suppl):1194-9. PubMed ID: 17824239 [No Abstract] [Full Text] [Related]
28. Mucosal administration of completely non-replicative vaccinia virus recombinant Dairen I strain elicits effective mucosal and systemic immunity. Yoshino N, Kanekiyo M, Hagiwara Y, Okamura T, Someya K, Matsuo K, Ami Y, Sato S, Yamamoto N, Honda M. Scand J Immunol; 2008 Nov 01; 68(5):476-83. PubMed ID: 18803609 [Abstract] [Full Text] [Related]
29. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. Abe N, Kodama S, Hirano T, Eto M, Suzuki M. Laryngoscope; 2006 Mar 01; 116(3):407-12. PubMed ID: 16540899 [Abstract] [Full Text] [Related]
30. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J. J Clin Virol; 2004 Dec 01; 31 Suppl 1():S99-106. PubMed ID: 15567101 [Abstract] [Full Text] [Related]
31. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation. Kuo E, Bharat A, Goers T, Chapman W, Yan L, Street T, Lu W, Walter M, Patterson A, Mohanakumar T. Ann Thorac Surg; 2006 Sep 01; 82(3):1043-50. PubMed ID: 16928532 [Abstract] [Full Text] [Related]
32. Histology and immunohistology of IgA nephropathy. Haas M. J Nephrol; 2005 Sep 01; 18(6):676-80. PubMed ID: 16358224 [Abstract] [Full Text] [Related]
33. Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease. Nagahama K, Maru K, Kanzaki S, Chai HL, Nakai T, Miura S, Yamaguchi A, Yamanaka S, Nagashima Y, Aoki I. Clin Exp Immunol; 2005 Aug 01; 141(2):215-22. PubMed ID: 15996185 [Abstract] [Full Text] [Related]
34. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization. Darvill AM, Ballardie FW. J Lab Clin Med; 2006 Jun 01; 147(6):301-9. PubMed ID: 16750668 [Abstract] [Full Text] [Related]
35. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice. Huang CF, Wang CC, Wu TC, Wu KG, Lee CC, Peng HJ. J Pediatr Gastroenterol Nutr; 2008 Mar 01; 46(3):262-71. PubMed ID: 18376242 [Abstract] [Full Text] [Related]
37. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae. Shah P, Briles DE, King J, Hale Y, Swiatlo E. Exp Biol Med (Maywood); 2009 Apr 01; 234(4):403-9. PubMed ID: 19176871 [Abstract] [Full Text] [Related]
38. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. J Virol; 2006 Sep 01; 80(17):8530-40. PubMed ID: 16912303 [Abstract] [Full Text] [Related]
39. [A study of Ig-A nephropathy in children and adults with chance proteinuria and/or hematuria (author's transl)]. Katsura H, Arai M, Yamaguchi M, Okada M, Sugisaki T, Shiwachi S, Ito S, Yonekura M, Shigeru, Sato, Kitazawa K, Yamamoto J. Nihon Jinzo Gakkai Shi; 1978 Jul 01; 20(7):785-96. PubMed ID: 722979 [No Abstract] [Full Text] [Related]
40. [Immunoglobulin A and renal diseases]. Matousovic K, Mestecky J, Tomana M, Novak J. Vnitr Lek; 2006 Mar 01; 52(3):256-62. PubMed ID: 16722157 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]